C3TD078
C3TD078 is a WDR5 WIN site inhibitor with a Ki of 0.03 nM. C3TD078 has potent antiproliferative activity and reduces the stem-cell frequency of cancer stem cells (CSCs) . C3TD078 can be used for glioblastoma (GBM) research[1].
Product Specifications
UNSPSC
12352005
Target
WDR5
Related Pathways
Epigenetics
Field of Research
Cancer
Smiles
FC(C1=NN(C)C=C1C2=CC(CN3C=CN=C3C)=CC4=C2CCC5=C4N=NN5CC6=CC(OC)=CC(OC)=C6)(F)F
Molecular Formula
C29H28F3N7O2
Molecular Weight
563.57
References & Citations
[1]Coker J A, et al. Development and Characterization of Triazole-Based WDR5 Inhibitors for the Treatment of Glioblastoma[J]. bioRxiv, 2025: 2025.07. 29.667410.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1191905-01 0.02 mg (E-Coli)
Recombinant Mouse Serum paraoxonase/arylesterase 1 (Pon1)
Ask
View Details 
MBS1191905-02 0.1 mg (E-Coli)
Recombinant Mouse Serum paraoxonase/arylesterase 1 (Pon1)
Ask
View Details MBS1191905-03 1 mg (E-Coli)
Recombinant Mouse Serum paraoxonase/arylesterase 1 (Pon1)
Ask
View Details MBS1191905-04 5x 1 mg (E-Coli)
Recombinant Mouse Serum paraoxonase/arylesterase 1 (Pon1)
Ask
View Details 
